We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 100

Futurecare of North Carolina a new voice for change for long term care
  • Poyner Spruill LLP
  • USA
  • October 31 2010

In 2007, the North Carolina Health Care Facilities Association, the trade association for skilled nursing care facilities in the state, saw the need for a new research and education initiative that would focus on efforts to address the many issues affecting the quality and performance of the nursing home industry, with an emphasis on innovative approaches to long-standing issues in both medicalnursing care as well as in residential quality of life.


National suture class action rejected
  • Epstein Becker Green
  • USA
  • December 2 2009

The Mass Tort Defense Blog reported recently that the North Carolina federal district court overseeing the MDL concerning panacryl sutures declined last week to certify a proposed national class action in In re Panacryl Sutures Products Liability Cases.


Apotex alleges it is injured by Ranbaxy's ability to launch on schedule
  • Gowling WLG
  • USA
  • July 27 2009

In two different cases before the US District Court for the Middle District of North Carolina Apotex has alleged that Ranbaxy's inability to launch its generic versions of donepezil hydrochloride (sold by Eisai Co. under the brand Aricept) and valacyclovir hydrochloride (sold by GSK under the brand Valtrex) on time will injure Apotex.







Isabel Raasch
  • Gowling WLG